Profound Medical Analyst Ratings
Profound Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/04/2023 | — | Raymond James | Downgrades | Strong Buy → Outperform | |
| 05/11/2023 | 77.87% | TD Cowen | $14 → $18 | Maintains | Outperform |
| 05/11/2023 | 55.63% | Alliance Global Partners | $13.15 → $15.75 | Maintains | Buy |
| 03/21/2023 | -1.19% | Jefferies | $5.5 → $10 | Downgrades | Buy → Equal-Weight |
| 11/04/2022 | — | Raymond James | Upgrades | Outperform → Strong Buy | |
| 03/07/2022 | 38.34% | Cowen & Co. | $28 → $14 | Maintains | Outperform |
| 02/22/2022 | 127.27% | Raymond James | $28 → $23 | Downgrades | Strong Buy → Outperform |
| 09/15/2020 | — | Jefferies | Initiates Coverage On | → Buy | |
| 09/10/2020 | 117.39% | Lake Street | → $22 | Initiates Coverage On | → Buy |
| 04/01/2020 | 48.22% | Cowen & Co. | → $15 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/04/2023 | - | 雷蒙德·詹姆斯 | 評級下調 | 強勢買入→跑贏大盤 | |
| 2023年05月11日 | 77.87% | TD Cowen | $14→$18 | 維護 | 跑贏大盤 |
| 2023年05月11日 | 55.63% | 聯盟全球合作夥伴 | $13.15→$15.75 | 維護 | 買 |
| 03/21/2023 | -1.19% | 傑富瑞 | $5.5→$10 | 評級下調 | 購買→等重產品 |
| 11/04/2022 | - | 雷蒙德·詹姆斯 | 升級 | 跑贏→強勢買入 | |
| 03/07/2022 | 38.34% | 考恩公司 | $28→$14 | 維護 | 跑贏大盤 |
| 02/22/2022 | 127.27% | 雷蒙德·詹姆斯 | $28→$23 | 評級下調 | 強勢買入→跑贏大盤 |
| 2020/09/15 | - | 傑富瑞 | 開始承保 | →購買 | |
| 09/10/2020 | 117.39% | 萊克街 | →$22 | 開始承保 | →購買 |
| 04/01/2020 | 48.22% | 考恩公司 | →$15 | 開始承保 | →跑贏大盤 |
What is the target price for Profound Medical (PROF)?
深奧醫療(教授)的目標價是多少？
The latest price target for Profound Medical (NASDAQ: PROF) was reported by Raymond James on August 4, 2023. The analyst firm set a price target for $0.00 expecting PROF to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
深奧醫療(納斯達克：PRO)的最新目標價是由Raymond James於2023年8月4日報道的。這家分析公司將目標價定為0.00美元，預計Prof將在12個月內下跌(跌幅可能為-100.00%)。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for Profound Medical (PROF)?
深奧醫療(教授)的最新分析師評級是多少？
The latest analyst rating for Profound Medical (NASDAQ: PROF) was provided by Raymond James, and Profound Medical downgraded their outperform rating.
深奧醫療(納斯達克：PROF)的最新分析師評級由Raymond James提供，深奧醫療下調了其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Profound Medical (PROF)?
深奧醫療(教授)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Profound Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Profound Medical was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與深奧醫療的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。深奧醫療的上一次評級是在2023年8月4日提交的，所以你應該預計下一次評級將在2024年8月4日左右的某個時候提供。
Is the Analyst Rating Profound Medical (PROF) correct?
分析師對深奧醫療(教授)的評級正確嗎？
While ratings are subjective and will change, the latest Profound Medical (PROF) rating was a downgraded with a price target of $0.00 to $0.00. The current price Profound Medical (PROF) is trading at is $10.12, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的深層醫療(教授)評級為下調，目標價為0.00美元至0.00美元。深奧醫療(教授)目前的交易價格為10.12美元，超出了分析師的預測範圍。